Cargando…
Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape Enhancers
The toxic moiety of almost all protein-based targeted toxins must enter the cytosol of the target cell to mediate its fatal effect. Although more than 500 targeted toxins have been investigated in the past decades, no antibody-targeted protein toxin has been approved for tumor therapeutic applicatio...
Autores principales: | Fuchs, Hendrik, Weng, Alexander, Gilabert-Oriol, Roger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963833/ https://www.ncbi.nlm.nih.gov/pubmed/27376327 http://dx.doi.org/10.3390/toxins8070200 |
Ejemplares similares
-
Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy
por: Gilabert-Oriol, Roger, et al.
Publicado: (2014) -
Glycosylated Triterpenoids as Endosomal Escape Enhancers in Targeted Tumor Therapies
por: Fuchs, Hendrik, et al.
Publicado: (2017) -
Reporter Assay for Endo/Lysosomal Escape of Toxin-Based Therapeutics
por: Gilabert-Oriol, Roger, et al.
Publicado: (2014) -
Enhanced cytotoxicity of a Pseudomonas Exotoxin A based immunotoxin against prostate cancer by addition of the endosomal escape enhancer SO1861
por: Masilamani, Anie P., et al.
Publicado: (2023) -
Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. Toxins 2022, 14, 478
por: Panjideh, Hossein, et al.
Publicado: (2022)